|
|
| |
A proprietary technology for fast and complete drug loading in liposome formulation. |
|
| |
|
|
| |
 |
|
| |
|
|
| |
| |
|
|
Encapsulate the drugs in liposome as an injectable dosage |
| |
|
|
| Efficiently encapsulate various drug in liposomes e.g. weak base drug, adriamycins, vinca alkaloids, camptothecins |
|
Change PK and increase circulation time (T1/2)
|
Decrease side effect
|
| Passive target to tumor and inflammatory sites |
Protect the fragile drug from enzyme or pH impact
|
|
|
|
|
|
|
|
|
|
|
